Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 9/20 | 0.31 |
| ▸ | CA2 | P00918 | 9/20 | 0.31 |
| ▸ | CA9 | Q16790 | 9/20 | 0.31 |
| ▸ | CA12 | O43570 | 4/20 | 0.31 |
| ▸ | THRB | P10828 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.30 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.30 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.30 |
| ▸ | CA3 | P07451 | 2/20 | 0.30 |
| ▸ | CA4 | P22748 | 2/20 | 0.30 |
| ▸ | CA6 | P23280 | 2/20 | 0.30 |
| ▸ | CA5A | P35218 | 2/20 | 0.30 |
| ▸ | CA7 | P43166 | 2/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.30 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2340852 | 0.98 | THRB (0.35) | CA1CA2CA9CA12THRB | |
| SCHEMBL2345783 | 0.98 | THRB (0.35) | CA1CA2CA9CA12THRB | |
| SCHEMBL2344612 | 0.98 | THRB (0.35) | CA1CA2CA9CA12THRB | |
| SCHEMBL2341006 | 0.98 | THRB (0.35) | CA1CA2CA9CA12THRB | |
| SCHEMBL2344571 | 0.98 | THRB (0.35) | CA1CA2CA9CA12THRB | |
| SCHEMBL2343297 | 0.93 | ADRB2 (0.35) | TSHR | |
| SCHEMBL2322677 | 0.91 | CA1 (0.33) | CA1CA2CA9CA12THRB | |
| SCHEMBL2325605 | 0.88 | THRB (0.38) | CA1CA2CA9CA12THRB | |
| SCHEMBL2340104 | 0.88 | — | — | |
| SCHEMBL2322189 | 0.88 | THRB (0.38) | CA1CA2CA9CA12THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1760085-B1 | PROCESS FOR PRODUCTION OF ALKYLTIN ALKOXIDES | ASAHI KASEI CHEMICALS CORP (JP) | 2014-02-26 | — | — | EP | disclosed |
| EP-1640357-B1 | METHOD FOR PRODUCING AROMATIC CARBONATE | ASAHI KASEI CHEMICALS CORP (JP) | 2011-08-31 | — | — | EP | disclosed |
| US-7652122-B2 | Method for producing an aromatic carbonate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2010-01-26 | — | — | US | disclosed |
| US-7541482-B2 | Process for production of alkyltin alkoxides | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2009-06-02 | — | — | US | disclosed |
| US-20080275262-A1 | Process for Production of Alkyltin Alkoxides | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2008-11-06 | — | — | US | disclosed |
| US-20070055042-A1 | Method for producing an aromatic carbonate | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2007-03-08 | — | — | US | disclosed |
| EP-1760085-A1 | PROCESS FOR PRODUCTION OF ALKYLTIN ALKOXIDES | Asahi Kasei Chemicals Corporation (JP) | 2007-03-07 | — | — | EP | disclosed |
| EP-1640357-A1 | METHOD FOR PRODUCING AROMATIC CARBONATE | Asahi Kasei Chemicals Corporation (JP) | 2006-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080275262-A1 | Process for Production of Alkyltin Alkoxides | ALK, MOGAT2, SOAT2 | CA1 4399/4885CA2 4090/4885CA9 2647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.